For decades, the Medical Representative has been the backbone of the pharmaceutical industry.
No product launch, brand strategy, or market expansion truly succeeded without the relentless field presence of MRs.
Yet today, across the industry, there is an uncomfortable silence around a growing problem. The MR model is under stress. Everyone senses it. Few openly discuss it.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
